Could a tiny dose of blood thinner slash stroke risk in seniors?
NCT ID NCT07454707
First seen Mar 19, 2026 · Last updated May 01, 2026 · Updated 6 times
Summary
This study tests whether adding a very low dose of the blood thinner edoxaban (15 mg daily) to standard aspirin or clopidogrel therapy can better prevent recurrent strokes in people aged 75 and older who have had an ischemic stroke. About 1,200 participants will be randomly assigned to receive either the added blood thinner or standard care alone. The goal is to see if this combination reduces stroke risk without causing dangerous bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE, ISCHEMIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.